The latest May 2026 issue of the prestigious Japanese food industry journal features a groundbreaking report on ingredient trends! Authored by Dr. Koji Kajima, a prominent Japanese biomedical researcher known for his work in phytomedicine and nutritional science. The article delivers an in-depth analysis of RenoSorb™ series ingredients and the application as formulation—boost a novel series of functional ingredients meticulously designed for the fast-growing market on women healthcare.
While traditional plant polyphenols and flavonoids often face limitations due to poor bioavailability or overly rapid absorption spikes, the RenoSorb™ series ingredients completely redefines the category. Harnessing the power of natto fermentation to achieve molecular diversification, this proprietary lineup unlocks a highly unique “Biphasic Sustained Profile” in blood concentration levels.
🔬 Core Technical Highlights (Backed by Science)
- Advanced Fermentation Technology: Leverages natto fermentation to transform flavonoids into modified derivatives (such as phosphorylated conjugates), significantly boosting bioavailability.
- Enterohepatic Circulation Mechanism: Enables sustained utilization within the body. The ingredients undergo initial intestinal absorption, hepatic metabolism, and biliary excretion, followed by an efficient secondary reabsorption process.
- Innovative Dual-Peak (Biphasic) Profile: Unlike standard aglycone forms that exhibit a sharp, single absorption peak, RenoSorb™ delivers a gradual rise and a secondary peak, drastically extending the active window and residence time of the nutrients in the systemic circulation.
This versatile ingredient platform offers incredible potential for women’s health, vitality, and healthy aging (RenoFlavone™), while seamlessly expanding into metabolism and circulation support (RenoCidin™) as well as body conditioning (RenoSage™). It provides nutraceutical brands with a powerful, scientifically backed marketing narrative.
